CorVista Health, has announced that the American Medical Association (AMA) has granted a new Category III Current Procedural Terminology (CPT®) code for novel augmentative AI algorithmic analysis of ...

News and commentary from the endocrinology world ...

Sportschosun reporter Jang Jong-ho] The Korean Society of Pulmonary Hypertension, led by President Jung Wook-jin, held the ...

For the first time, patients have received a new injection for chronic obstructive pulmonary disease (COPD), thanks to ...

Introduction Efficient preventive management of acute exacerbation of chronic obstructive pulmonary disease (COPD) is ...

Protocol can be used in children and pregnant women ...

Rapid advances in artificial intelligence (AI), computational medicine, and digital health are fundamentally reshaping respiratory and critical care ...

A doctor and patient both offer their perspectives on the challenges of returning home from the hospital after a COPD ...

Treatment options for managing your PH will depend on what type of pulmonary hypertension you have. Each type of pulmonary hypertension requires a tailored treatment plan that follows the latest ...

Clinical Question: Can d-dimers rule out pulmonary embolisms when not “within normal limits?” Background: D-dimer tests are frequently ordered at low clinical thresholds, but values not “within normal ...

This section describes the evidence gaps, why they need to be addressed and their relative importance for future committee decision making. The committee will not be able to make a positive ...

Table 1 summarises the evidence gaps and ongoing studies that might address them. Information about evidence status is derived from the external assessment report. More information on the studies in ...